Home Interior Collections

Buying Influence – How the Drug Makers Achieve Corporate Mind Control

The National Alliance on Mental Illness is one of the United States’ most influential disease advocacy groups. Congressional investigators have discovered that a majority of the donations made to the NAMI come from drug manufacturers.NAMI is not unique in its enrichment by psycho-pharmacy money, far from it, but it serves as an example by which we can see how the psycho-pharmaceutical axis buys undue influence over other groups, including governments and media.

The purpose of the manufacturers of psychiatric drugs is to sell psychiatric drugs and part and parcel of selling a drug is to convince all and sundry that they need them. The assiduousness and indeed ruthlessness with which the drug corporations pursue that agendum is well documented. Indeed, their success in working hand in glove with psychiatry to convince the population to pop a pill at every opportunity has effectively herded the culture into a mire of drug dependency from which it may not recover. methylone for sale It is a great tragedy that the products being pushed off on the rest of us, drugs, do such devastating harm.

This is no more epitomized than by revelations that drug companies may be designing their drugs to be addictive. Certainly the addictiveness of a drug enables more to be sold and greater long-term profits to be made.

One would have thought that advocacy of mental health would include real efforts to get people off drugs or steer them away from them, considering the damage they do to physical and mental health, yet NAMI has long been criticized for coordinating its lobbying efforts with drug makers and for pushing legislation 4 aco dmt buybenefits the drugs industry.

There is little if any campaigning, for instance, to address known causes of the difficulties labelled “mental illness,” such as poor nutrition, to take one key example. Almost any nutritional deficiency can produce depression and the list of physical illnesses that can have depression as a symptom is a very long one. Yet the handling of the underlying medical condition is rarely, if ever, promoted by the psycho-pharmacy.

There is no profit, let’s face it, for the drugs makers in advocating proper nutrition or making someone truly well. The poor patient is then drugged instead, setting in train complications with ill health, brain damage, addiction and so forth. Those complications are of course profitable for the psycho-pharmacy.As part of his investigation into the drugs industry’s influence on the practice of medicine, Senator Charles E. Grassley (Republican Iowa) last spring sent letters to the NAMI and about a dozen similar organizations, enquiring about their connections to drug makers.

The NAMI, which exerts considerable influence in many state capitols, has refused for years to disclose specifics of its fund-raising, claiming the details were private. However, investigators in Mr. Grassley’s office and The New York Times were able to expose the fact that from 2006 to 2008 drug makers contributed nearly $23 million to NAMI, which is a staggering three quarters of all its donations.

This is an excessive level of donations from a vested interest private-profit corporation whose objective is to sell as many drugs as possible. It is difficult to see how an organization such as NAMI, which would be four times poorer without this stream of drug company money, would not be influenced by it and one cannot imagine the drugs companies would part with so many millions if they were not receiving, in their perception, their money’s worth.Even the NAMI’s executive director, Michael Fitzpatrick, admitted in an interview that the drug companies’ donations were excessive and that things would change.